Literature DB >> 17302995

Relationship between upregulation of CD40 system and restenosis in patients after percutaneous coronary intervention.

Jin-Chuan Yan1, Shu Ding, Yi Liang, Gen-Shan Ma, Jian Zhu, Yi Feng, Dan Luo.   

Abstract

AIM: To investigate whether the increasing CD40-CD40 ligand system is related to restenosis in patients after percutaneous coronary intervention (PCI).
METHODS: Twenty normal controls and 120 patients with PCI were investigated. The expression of CD40 and the CD40 ligand (CD40L) on platelets was analyzed by indirectimmunofluorescence flow cytometry. The serum level of soluble CD40L (sCD40L) and C-reactive protein (CRP) was determined by commercially available enzyme linked immunosorbent assay. Restenosis was observed in 120 patients within a 6 month follow-up period after PCI surgery.
RESULTS: Restenosis occurred in 29 patients (24.2%). Patients who developed restenosis showed higher levels of CD40-CD40L system compared with non-restenotic patients before PCI. All restenotic patients showed a significant increase in CD40 [66.9 +/-4.8, mean fluorescence intensity (MFI)] and CD40L (14.9 +/-1.8, MFI) co-expression on platelets as well as sCD40L (13.7 +/-1.7 ng/mL) compared with non-restenotic patients and controls during the 6 month follow-up period (P<0.01). Elevated sCD40L and CD40L were significantly correlated with the serum level of CRP after percutaneous transluminal coronary angioplasty and with lumen loss during the 6 month followup period.
CONCLUSION: The level of CD40L was associated with late restenosis after PCI indicating that restenosis is an inflammatory disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17302995     DOI: 10.1111/j.1745-7254.2007.00520.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  2 in total

1.  The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women.

Authors:  I Lambrinoudaki; M Karaflou; G Kaparos; O Grigoriou; A Alexandrou; C Panoulis; E Logothetis; M Creatsa; G Christodoulakos; E Kouskouni
Journal:  J Endocrinol Invest       Date:  2010-04-30       Impact factor: 4.256

2.  Vitamin D decreases CD40L gene expression in ulcerative colitis patients: A randomized, double-blinded, placebo-controlled trial.

Authors:  Amrollah Sharifi; Homayoon Vahedi; Mohammad Reza Honarvar; Taghi Amiriani; Zeinab Nikniaz; Esmaeil Yousefi Rad; Mohammad Javad Hosseinzadeh-Attar
Journal:  Turk J Gastroenterol       Date:  2020-02       Impact factor: 1.852

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.